Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 18, 2016 02:00 ET | Source: Midatech Pharma PLC

Midatech Pharma announces clinical pipeline update

ABINGDON, England, May 18, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM: MTPH; Nasdaq: MTP), the international specialty pharmaceutical company focused on commercialising and developing products...
May 11, 2016 12:44 ET | Source: Midatech Pharma PLC

Result of Annual General Meeting

ABINGDON, England, May 11, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM: MTPH; Nasdaq: MTP), the international specialty pharmaceutical company focused on commercialising and developing products...
May 11, 2016 02:00 ET | Source: Midatech Pharma PLC

AGM Statement and Update on Trading

ABINGDON, England, May 11, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM: MTPH; Nasdaq: MTP), the international specialty pharmaceutical company focused on commercialising and developing...
April 26, 2016 02:00 ET | Source: Midatech Pharma PLC

Midatech Pharma announces positive pharmacokinetic data with Q-Octreotide

ABINGDON, England, April 26, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH; Nasdaq:MTP), the international specialty pharmaceutical company focused on commercialising and developing products in...
April 21, 2016 02:00 ET | Source: Midatech Pharma PLC

Midatech achieves positive dosing data for OpsiSporin Uveitis programme

ABINGDON, England, April 21, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH) (Nasdaq:MTP), the international specialty pharmaceutical company focused on commercialising and developing products...
April 13, 2016 02:00 ET | Source: Midatech Pharma PLC

Midatech Pharma PLC (“Midatech” or the “Company”) Audited financial results for the year ended 31 December 2015

Midatech will host a conference call and live Q&A session today (Wednesday 13 April 2016) at 1300 BST / 0800 EDT for analysts and investors to discuss the Annual Results. Dr Jim Phillips, Chief...
April 11, 2016 02:00 ET | Source: Midatech Pharma PLC

Midatech’s Commercial Launch of Zuplenz® (Ondansetron) Oral Soluble Film to Prevent Post-Operative, Chemotherapy and Radiation-Induced Nausea and Vomiting in US

ABINGDON, England, April 11, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH); (Nasdaq:MTP), the international specialty pharmaceutical company focused on commercialising and developing...
February 29, 2016 02:00 ET | Source: Midatech Pharma PLC

Midatech Pharma Recognises International Rare Disease Day 2016

ABINGDON, Va., Feb. 29, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH), (Nasdaq:MTP), the international specialty pharmaceutical company focused on developing and commercialising products in...
January 07, 2016 16:00 ET | Source: Midatech Pharma PLC

Midatech Pharma to Present at Biotech Showcase™ 2016

OXFORD, United Kingdom, Jan. 07, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH) (Nasdaq:MTP), the international specialty pharmaceutical company focused on developing and commercialising...
January 06, 2016 02:00 ET | Source: Midatech Pharma PLC

Midatech Pharma PLC (“Midatech”, the “Company” or the “Group”) Pre-Close Trading Update

OXFORD, United Kingdom, Jan. 06, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH, Nasdaq: MTP), the international specialty pharmaceutical company focused on developing and commercialising...

Next Page keyboard_arrow_right